ICCM Comptes : Analyse IA Icecure Medical Ltd



Comptes financiers

ICCM Financier

Icecure Medical Ltd

$0.28

1.39%

$0

À la fermeture : Apr 27, 16:00:00 GMT-4

$0.27

-3.52%

$0

Pré-Marché: Apr 28, 09:19:12 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$0.2801

Prix d'ouverture

$0.3

Plage de la journée

$0.274 - $0.3

Plage de 52 semaines

$0.274 - $1.4

Volume

465.1K

Volume moyen

445.9K

Rendement en dividend

BPA (TTM)

-0.24

Capitalisation boursière

$22.2M

Qu’est-ce que ICCM ?

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Fonctionnalités

Ressources

Marché

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

ICCM Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenus	3	1	0	0	0	0
Croissance des revenus (H/H)	0%	--	--	-100%	--	-100%
Coût des ventes	2	0	0	0	0	0
Bénéfice brut	1	0	0	0	0	0
Vente, Général et Administration	8	2	2	1	2	3
Recherche et développement	7	2	1	1	1	1
Frais d'exploitation	16	4	4	3	3	4
Autres revenus (charges) non opérationnels	--	--	--	--	--	--
Bénéfice avant impôts	-15	-4	-3	-3	-3	-4
Charge d'impôt sur le revenu	--	--	--	--	--	--
Bénéfice net	-15	-4	-3	-3	-3	-4
Croissance du bénéfice net	0%	0%	-25%	0%	0%	100%
Actions en circulation (diluées)	72.61	72.61	65.39	58.67	57.63	56
Variation des actions (H-H)	30%	30%	26%	20%	23%	23%
EPS (dilué)	-0.2	-0.05	-0.05	-0.05	-0.06	-0.08
Croissance du EPS	-26%	-27%	-26%	-9%	-19%	22%
Flux de trésorerie libre	-14	-5	-2	-2	-4	-4
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	33.33%	0%	0%	0%	0%	0%
Marge opérationnelle	-500%	-400%	0%	0%	0%	0%
Marge bénéficiaire	-500%	-400%	0%	0%	0%	0%
Marge du flux de trésorerie libre	-466.66%	-500%	0%	0%	0%	0%
EBITDA	-15	-4	-3	-3	-3	-4
Marge EBITDA	-500%	-400%	0%	0%	0%	0%
D&A pour le résultat opérationnel	0	0	0	0	0	0
EBIT	-15	-4	-3	-3	-3	-4
Marge EBIT	-500%	-400%	0%	0%	0%	0%
Taux d'imposition effectif	--	--	--	--	--	--

Follow-Up Questions

Icecure Medical Ltd의 주요 재무제표는 무엇인가요?



최신 재무제표(Form-10K)에 따르면, Icecure Medical Ltd의 총 자산은 $0이며, 순perte입니다.

ICCM의 주요 재무 비율은 무엇인가요?



Icecure Medical Ltd의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.

Icecure Medical Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?



Le segment de revenus le plus important est Icecure Medical Ltd, avec un chiffre d'affaires de Disposables lors du dernier rapport de résultats. En termes géographiques, United States est le marché principal pour Icecure Medical Ltd, avec un chiffre d'affaires de 908,000.

Icecure Medical Ltd은 수익성이 있나요?



non, 최신 재무제표에 따르면 Icecure Medical Ltd의 순perte은 $0입니다.

Icecure Medical Ltd에 부채가 있나요?



non, Icecure Medical Ltd의 부채는 0입니다.

Icecure Medical Ltd의 발행 주식은 몇 주인가요?



Icecure Medical Ltd의 총 발행 주식은 0주입니다.

Icecure Medical Ltd (ICCM) Financier

Graphique du cours de l'action ICCM